Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis

被引:36
作者
Godballe, C [1 ]
Asschenfeldt, P
Jorgensen, KE
Bastholt, L
Clausen, PP
Hansen, TP
Hansen, O
Bentzen, SM
机构
[1] Odense Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark
[3] Odense Univ Hosp, Dept Oncol, DK-5000 Odense C, Denmark
[4] Danish Canc Soc, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark
关键词
D O I
10.1097/00005537-199802000-00016
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To identify clinical and histologic prognostic factors and to investigate whether immunohistochemical detection of p53 expression might contain prognostic information, a retrospective study of patient and tumor characteristics was performed in 225 cases of papillary and follicular thyroid carcinomas. The analyses were based on cause specific and crude survival. In univariate analysis, age at diagnosis, tumor size, presence of distant metastases, histology (papillary contra follicular type), extrathyroidal invasion, necrosis in primary tumor, and p53 expression were significant prognostic indicators. For 211 patients (96%) all information was available and Cox's proportional hazard model was applied. The authors found that age, distant metastases, necrosis in primary tumor, extrathyroidal invasion, and p53 expression were significant prognostic factors. Analyses of cause-specific and crude survival gave similar results. The authors conclude that age at diagnosis, presence of distant metastases, necrosis in primary tumor, and extrathyroidal invasion are important prognostic factors, and that immunohistochemical detection of p53 protein in the primary tumor is a significant and independent prognostic indicator, which might be of value in the treatment planning in patients with papillary or follicular thyroid carcinomas.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 38 条
[1]   PROGNOSTIC IMPORTANCE OF VARIOUS CLINICOPATHOLOGICAL FEATURES I PAPILLARY THYROID-CARCINOMA [J].
AKSLEN, LA ;
MYKING, AO ;
SALVESEN, H ;
VARHAUG, JE .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) :44-51
[2]  
Armitage P., 1971, STAT METHODS MED RES
[3]   PROGNOSTIC INDEX FOR THYROID-CARCINOMA - STUDY OF THE EORTC-THYROID-CANCER-COOPERATIVE-GROUP [J].
BYAR, DP ;
GREEN, SB ;
DOR, P ;
WILLIAMS, ED ;
COLON, J ;
VANGILSE, HA ;
MAYER, M ;
SYLVESTER, RJ ;
VANGLABBEKE, M .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (08) :1033-1041
[4]  
CADY B, 1979, CANCER, V43, P810, DOI 10.1002/1097-0142(197903)43:3<810::AID-CNCR2820430306>3.0.CO
[5]  
2-B
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781
[8]   OVEREXPRESSION OF P53 AS A POSSIBLE PROGNOSTIC FACTOR IN HUMAN THYROID-CARCINOMA [J].
DOBASHI, Y ;
SAKAMOTO, A ;
SUGIMURA, H ;
MERNYEI, M ;
MORI, M ;
OYAMA, T ;
MACHINAMI, R .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (04) :375-381
[9]   STEPWISE PARTICIPATION OF P53 GENE MUTATION DURING DEDIFFERENTIATION OF HUMAN THYROID CARCINOMAS [J].
DOBASHI, Y ;
SUGIMURA, H ;
SAKAMOTO, A ;
MERNYEI, M ;
MORI, M ;
OYAMA, T ;
MACHINAMI, R .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1994, 3 (01) :9-14
[10]   GENE P53 MUTATIONS ARE RESTRICTED TO POORLY DIFFERENTIATED AND UNDIFFERENTIATED CARCINOMAS OF THE THYROID-GLAND [J].
DONGHI, R ;
LONGONI, A ;
PILOTTI, S ;
MICHIELI, P ;
DELLAPORTA, G ;
PIEROTTI, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1753-1760